Biden Team Eyes End Of COVID Emergency Declaration And Shift In Covid Team

When the Biden administration renews the Covid public health emergency this week, it will mark the 11th time since the coronavirus arrived that the government declared its presence a national crisis. It may also be the last. Senior Biden officials are targeting an end to the emergency designation for Covid as soon as the spring, ...

Read More

Sen. Bernie Sanders To Target High Healthcare Costs As Leader Of Influential Committee

Longtime Congressman Sen. Bernie Sanders, I-Vt., is expected next month to take the helm of the Senate’s Health, Education, Labor and Pensions Committee, bringing the Medicare-for-All proponent center stage in one of the nation’s most broadly influential health policy forums. The anticipated appointment comes after the current committee chair Sen. Patty Murray, D-Wash., announced that ...

Read More

Behavioral Telehealth Loses Momentum Without a Regulatory Boost

Controlled substances became a little less controlled during the pandemic. That benefited both patients (for their health) and telehealth startups (to make money). Some potentially addictive medications — like buprenorphine and Adderall — are now far more available online to patients because of regulatory changes. Given the scarcity of qualified doctors to treat some of ...

Read More

Expanded ACA Subsidies Help More Nevadans Get Health Care Coverage

Open enrollment for health insurance plans in Nevada ends on Jan 15. It’s anticipated to be the largest enrollment for plans offered under the Affordable Care Act (ACA) in the state’s history, a development that is happening nationwide.

Read More

OIG: CMS Needs To Help Drugmakers In Calculating Best Medicare Part B Prices

Drugmakers need more guidance from the Centers for Medicare & Medicaid Services (CMS) on how to calculate the best price for drugs sold on Medicare Part B, a key federal watchdog said.

Read More

Options For CMS Drug Price Negotiations

In 2026, the Inflation Reduction Act (IRA) will allow the Centers for Medicare and Medicaid Services (CMS) to negotiate the maximum price of certain prescription drugs on behalf of Medicare beneficiaries for the first time in the history of the program. While the IRA specifies the criteria for selecting drugs eligible for negotiations—brand-name drugs that do not ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square